The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of pembrolizumab and metronomic cyclophosphamide in patients with advanced sarcomas and GIST: A French Sarcoma Group phase II trial.
 
Maud Toulmonde
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Nicolas Penel
No Relationships to Disclose
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; HalioDx; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Pierre Fabre (Inst); Sanofi (Inst)
 
Christine Chevreau
Consulting or Advisory Role - BMS Brazil; Novartis; Pfizer
 
Jean-Yves Blay
Consulting or Advisory Role - BMS Brazil; Lilly; MSD; Novartis; PharmaMar; Roche
Research Funding - BMS Brazil; Lilly; MSD; Novartis; PharmaMar; Roche
 
Axel Le Cesne
Honoraria - Amgen; Lilly; Novartis; PharmaMar
 
Emmanuelle Bompas
No Relationships to Disclose
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Sophie Cousin
No Relationships to Disclose
 
Thomas Ryckewaert
No Relationships to Disclose
 
Alban Bessede
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
Honoraria - Immatics
Research Funding - Immatics
Patents, Royalties, Other Intellectual Property - immatics
Travel, Accommodations, Expenses - Immatics
 
Francois Ghiringhelli
No Relationships to Disclose
 
Thomas Grellety
No Relationships to Disclose
 
Marina Pulido
No Relationships to Disclose
 
Antoine Italiano
No Relationships to Disclose